FDA Lifts Hold on Concert Pharma ' s Study Testing Hair Loss Drug FDA Lifts Hold on Concert Pharma ' s Study Testing Hair Loss Drug

Concert Pharmaceuticals Inc said on Monday the U.S. Food and Drug Administration (FDA) lifted a clinical hold on a trial testing its therapy for alopecia areata, a type of hair loss.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Dermatology News Source Type: news